Seragon Pharmaceuticals
Date | Investors | Amount | Round |
---|---|---|---|
$30.0m | Series A | ||
$725m | Acquisition | ||
Total Funding | $30.0m |
Related Content
Recent News about Seragon Pharmaceuticals
EditSeragon Pharmaceuticals is a global biotechnology company specializing in innovative biomedical solutions aimed at improving human health and longevity. The company operates in the fast-paced and evolving home health market, leveraging its scientific expertise to identify and address gaps in modern healthcare. Seragon's core focus areas include immunology, gene therapy, and aging, providing cutting-edge treatments and therapies to enhance the immune system and combat serious diseases. The business model revolves around research and development, clinical trials, and commercialization of advanced biomedical products. Revenue is generated through the sale of these specialized treatments and therapies to healthcare providers, research institutions, and directly to consumers. Seragon's clients range from individual patients to large healthcare organizations, making it a key player in the biotechnology and home health sectors.
Keywords: biotechnology, biomedical design, home health, immunology, gene therapy, aging, healthcare solutions, clinical trials, innovative treatments, global market.